Tilray | TRLY - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acasti Pharma USD 1.25M 34K 2026-06
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alaunos Therapeutics USD 864K 269K 2026-06
Aurora Cannabis CAD 73.43M 6.5M 2026-06
Avita Medical AUD 68.71M 6.04M 2026-06
Canopy Growth CAD 166.75M 8.31M 2026-06
Cronos Group USD 56.36M 13.94M 2026-06
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
IQVIA Holdings USD 7.78B 1.04B 2026-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Moderna USD 2.53B 139M 2026-06
Organigram Holdings CAD 107.28M 18.54M 2026-06
Organon & Co USD 2.65B 36M 2026-09
Revvity USD 1.28B 37.71M 2026-06
Tectonic Therapeutic USD 10.37M 2.59M 2026-06
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 6.35B 464.5M 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zealand Pharma A/S 404M 260.96M 2026-03